By Series A, HIPAA stops being about foundations and starts being about proof. Bigger buyers, harder security reviews, and a growing team change what your program has to do. Here is how to level it up.
TL;DR
At Series A, the controls you built at seed need to become a formal, demonstrable program. Enterprise buyers and larger health systems run harder security reviews and increasingly expect attestations like SOC 2 alongside HIPAA.
The work shifts from building controls to formalising and proving them: mature policies, clear ownership, continuous evidence, and scaling access and training as your team grows. If you built the foundation at seed, Series A is about maturity, not starting over.
On this page
What changes at Series A
Series A changes who you sell to and how hard they look. The pilots and design partners of seed stage give way to larger customers, enterprises and established health systems, whose procurement and security teams run rigorous reviews. They are no longer satisfied by assurances that you take security seriously; they want evidence and, increasingly, formal attestations. At the same time your team is growing, which means more people can touch PHI and your access and training controls have to scale with them.
The HIPAA maturity curve
It helps to see Series A as a point on a curve rather than a fresh start.
If you set the foundation at seed, encryption, access control, logging, Series A is where you formalise it into an attested, demonstrable program, and where scaling begins in earnest. If you did not, Series A is where the gap becomes painful, because you are now retrofitting under buyer scrutiny.
What to formalise at Series A
The theme is turning working controls into a program you can prove and defend.
| Area | What formalising looks like |
|---|---|
| Policies | Complete, documented policies and procedures, not ad hoc practice |
| Ownership | Clear responsibility for security and compliance, even if part-time |
| Evidence | Continuous, organised evidence ready for buyer reviews and audits |
| Risk analysis | A maintained, recurring process, not a one-time seed exercise |
| Vendor management | A tracked inventory of BAAs as your vendor list grows |
Adding SOC 2 to HIPAA
Series A is the stage where SOC 2 usually enters the picture. Enterprise buyers frequently ask for a SOC 2 report as proof of security, on top of HIPAA. The good news is that the two overlap heavily: the safeguards you run for HIPAA cover much of what SOC 2 examines. Pursuing them together, rather than as separate programs, is far more efficient, and Series A, with real deals on the line, is typically when the investment pays off.
Scaling controls with your team
A growing headcount is its own compliance event. More engineers, support staff, and contractors means more people who can reach PHI, so least-privilege access, onboarding and offboarding discipline, and recurring training become essential rather than optional. Controls that were easy to manage informally at seed need to become systematic at Series A.
The lean-team path at Series A
Series A rarely comes with a big security team. You are formalising a program, adding SOC 2, and scaling access and training, usually with one person part-owning it. Doing that across disconnected tools, while under active buyer scrutiny, is exactly where it becomes overwhelming.
Turn your controls into a program buyers trust.
Osto is the one-stop cybersecurity and compliance platform built for fast-moving startups. Formalise HIPAA, add SOC 2 from the same controls, and scale with your team on one platform. No security team required.
Frequently asked questions
What changes about HIPAA at Series A?
The focus shifts from building controls to proving them. Larger enterprise buyers run harder security reviews and expect formal attestations, your team grows so access and training must scale, and your program needs to become demonstrable rather than informal.
Do Series A startups need SOC 2 as well as HIPAA?
Often yes. Enterprise buyers frequently request a SOC 2 report on top of HIPAA. Because the two share most of the same security controls, pursuing them together is far more efficient than running separate programs, and Series A is usually when it pays off.
What should a Series A startup formalise?
Complete documented policies, clear ownership of security and compliance, continuous and organised evidence, a maintained recurring risk analysis, and a tracked inventory of BAAs. The goal is turning working controls into a provable program.
How does a growing team affect HIPAA compliance?
Each new person who can access PHI expands your risk surface. Least-privilege access, disciplined onboarding and offboarding, and recurring training become essential at Series A, where informal management no longer scales safely.
What if we did not build HIPAA at seed?
Series A is where the gap becomes painful, because you are retrofitting foundational controls under active buyer scrutiny. It is still very achievable, but doing it on one platform that provides the controls and evidence together makes catching up far faster.
Can we handle Series A compliance without a security hire?
Yes, especially when the controls, evidence, and mappings to HIPAA and SOC 2 run on one platform. That consolidation is what lets a single part-time owner formalise, attest, and scale the program without a dedicated team.